RB_ASO 4:Commencing sales of CompuFlo Epidural disposables within the University Pain and Spine Center which operates 7 locations across New Jersey and New York
Firma: MILESTONE MEDICAL INCSpis treści:
1. RAPORT BIEŻĄCY
2. MESSAGE (ENGLISH VERSION)
3. INFORMACJE O PODMIOCIE
4. PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ
| KOMISJA NADZORU FINANSOWEGO | ||||||||||||
|
| Raport bieżący nr | 4 | / | 2023 | ||||||||
| Data sporządzenia: | 2023-03-14 | |||||||||||
| Skrócona nazwa emitenta | ||||||||||||
| MILESTONE MEDICAL | ||||||||||||
| Temat | ||||||||||||
| Commencing sales of CompuFlo Epidural disposables within the University Pain and Spine Center which operates 7 locations across New Jersey and New York | ||||||||||||
| Podstawa prawna | ||||||||||||
| Art. 17 ust. 1 MAR - informacje poufne. | ||||||||||||
| Treść raportu: | ||||||||||||
| The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company", “the Issuer"), today announced that it has commenced sales of CompuFlo® Epidural disposables into the University Pain and Spine Center, which operates 7 offices across New Jersey and New York. Adoption of the technology follows a successful evaluation by Dr. Didier Demesmin, MD, MBA. Dr. Demesmin is an interventional pain medicine physician who is board-certified in both anesthesiology and pain medicine. He is also the medical director and founder of the University Pain and Spine Center and is also affiliated with some of the most well-respected hospitals in Central New Jersey, such as Robert Wood Johnson University Hospital, JFK Medical Center, Somerset Medical Center, and Saint Peter’s University Hospital, where he is the director of pain medicine. The Board of Directors of the Company is delighted by the recent adoption of the technology by the University Pain and Spine Center following a successful evaluation period. The Board of Directors of the Company believes that the ability of the instrument to objectively measure tissue density, as well as provide both visual and audible confirmation of needle placement, can enhance both the speed and safety of the procedure, thereby providing a better experience for the provider and patient. | ||||||||||||
| MESSAGE (ENGLISH VERSION) | |||
|
| |||
| PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ | |||||
| Data | Imię i Nazwisko | Stanowisko/Funkcja | Podpis | ||
| 2023-03-14 | Keisha Harcum | Controller | Keisha Harcum | ||
Cena akcji Milestone
Cena akcji Milestone w momencie publikacji komunikatu to 1.95 PLN. Sprawdź ile kosztuje akcja Milestone aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Milestone.
